These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20530057)

  • 1. Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Mehri S; Attia N; Ben Farhat M; Hammami M
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):515-21. PubMed ID: 20530057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
    Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
    Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between Mediterranean diet and methylenetetrahydrofolate reductase C677T mutation on oxidized low density lipoprotein concentrations: the ATTICA study.
    Pitsavos C; Panagiotakos D; Trichopoulou A; Chrysohoou C; Dedoussis G; Chloptsios Y; Choumerianou D; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):91-9. PubMed ID: 16487909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
    Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
    Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels.
    Ilhan N; Kucuksu M; Kaman D; Ilhan N; Ozbay Y
    Arch Med Res; 2008 Jan; 39(1):125-30. PubMed ID: 18068006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H; Isbir S; Agachan B; Ergen A; Farsak B; Isbir T
    Cell Biochem Funct; 2006; 24(1):87-90. PubMed ID: 15648053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.
    Pereira AC; Miyakawa AA; Lopes NH; Soares PR; de Oliveira SA; Cesar LA; Ramires JF; Hueb W; Krieger JE
    Thromb Res; 2007; 121(1):25-32. PubMed ID: 17604826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors.
    Koubaa N; Nakbi A; Smaoui M; Abid N; Chaaba R; Abid M; Hammami M
    Clin Biochem; 2007 Sep; 40(13-14):1007-14. PubMed ID: 17618615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism.
    Gonzalez-Porras JR; Martin-Herrero F; Garcia-Sanz R; Lopez ML; Balanzategui A; Mateos MV; Pavon P; Gonzalez M; Alberca I; San Miguel JF
    Thromb Res; 2007; 119(6):691-8. PubMed ID: 17005242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.
    Rassoul F; Richter V; Hentschel B; Geisel J; Herrmann W; Kuntze T
    Indian J Med Res; 2008 Feb; 127(2):154-8. PubMed ID: 18403793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease.
    Bowron A; Scott J; Stansbie D
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):459-62. PubMed ID: 16259797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.